RLMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
RELMADA THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.16+0.06 (+1.94%)
Close on Oct 19, 2026
- Market cap
- $355.11M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Relmada Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 3, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 28, 2026 | Jul 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 27, 2026 | Apr 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 20, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2025 | Sep 17, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2025 | Sep 16, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2025 | Sep 10, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Sep 2, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2025 | Jul 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 18, 2025 | SEC EDGAR |
| Current report | 8-K | May 23, 2025 | May 27, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2025 | Apr 28, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 23, 2025 | Apr 11, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 26, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 3, 2025 | Feb 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2025 | Jan 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 1, 2025 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 9, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2024 | Dec 4, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |